2022 Saw More Than 2.5 Million Cases of Chlamydia, Gonorrhea, Syphilis

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Feb. 2, 2024 -- More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the United States in 2022, with concerns centering around syphilis and congenital syphilis, according to a report released Jan. 30 by the U.S. Centers for Disease Control and Prevention.

The CDC 2022 surveillance report presents recent data on sexually transmitted infections (STIs), focusing on trends in syphilis, gonorrhea, and chlamydia in the United States.

According to the report, syphilis cases are continuing to increase, with an increase of 17.0 percent over one year and of 78.9 percent over five years. Continuing increases were also observed in congenital syphilis, with increases of 30.6 and 183.4 percent over one and five years, respectively. Gonorrhea decreased 8.7 percent over one year, while chlamydia cases were stable (0.3 percent change over one year).

"There are no shortcuts, and we have to meet people where they are. Some people face tremendous barriers to STI prevention and health services," Laura Bachmann, M.D., M.P.H., from the Division of STD Prevention at the CDC, said in a statement. "So, the most important work is often outside the clinic, whether it be reaching out to communities with testing, interviewing patients to offer services to their partners, or delivering treatment directly to someone."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-02-03 08:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords